For example, in both gastric carcinoma and head and neck squamous cell carcinoma, the prediction of tumor response to ICI treatment was found to improve when immune cells were included in the PD-L1 scoring, as revealed in the KEYNOTE-012 and KEYNOTE-055 studies, respectively.7 This evidence concerns the gene CD274 and head and neck squamous cell carcinoma.